header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FISH-151211-4
Fish name: mo3Tg; mo5Tg
Genotype: mo3Tg; mo5Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by mo3Tg; mo5Tg
Human Disease Conditions Citations
nemaline myopathy standard conditions (2)
GENE EXPRESSION
Gene expression in mo3Tg; mo5Tg
RNA expression No data available
Protein expression No data available
PHENOTYPE
Phenotype in mo3Tg; mo5Tg
Phenotype Conditions Figures
myoseptum cellular anatomical entity aggregated, abnormal standard conditions Fig. 3 with image from Sztal et al., 2015
skeletal muscle decreased functionality, abnormal standard conditions Fig. 2 from Messineo et al., 2018
skeletal muscle decreased functionality, abnormal chemical treatment by environment: disodium L-tyrosinate Fig. 2 from Messineo et al., 2018
skeletal muscle structure, abnormal standard conditions Fig. 2 with image from Sztal et al., 2015
skeletal muscle actin filament accumulation skeletal muscle, abnormal standard conditions Fig. 2 with image from Sztal et al., 2015
skeletal muscle cellular anatomical entity aggregated, abnormal standard conditions Fig. 1 with imageFig. 2 with imageFig. 3 with image from Sztal et al., 2015
skeletal muscle filamentous actin distributed, abnormal standard conditions Fig. 2 with image from Sztal et al., 2015
skeletal muscle sarcomere disorganized, abnormal standard conditions Fig. 2 with image from Sztal et al., 2015
skeletal muscle sarcomere structure, abnormal standard conditions Fig. 2 with image from Sztal et al., 2015
swimming decreased process quality, abnormal standard conditions Fig. 4 with image from Sztal et al., 2015
swimming behavior process quality, abnormal chemical treatment by environment: disodium L-tyrosinate Fig. 2 from Messineo et al., 2018
swimming behavior process quality, abnormal standard conditions Fig. 2 from Messineo et al., 2018
thigmotaxis decreased process quality, abnormal standard conditions Fig. 4 with image from Sztal et al., 2015
whole organism decreased mobility, abnormal chemical treatment by environment: disodium L-tyrosinate Fig. 2 from Messineo et al., 2018
whole organism decreased mobility, abnormal standard conditions Fig. 2 from Messineo et al., 2018

CITATIONS  (2)